Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Trisomy 8”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Testing effectiveness (Phase 2)Study completedNCT01584531
What this trial is testing

Efficacy and Safety of Oral Rigosertib in Transfusion-dependent, Low or Int-1 or Trisomy 8 Int-2 Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromeMDSTrisomy 8
Traws Pharma, Inc. 82
Early research (Phase 1)Study completedNCT00533416
What this trial is testing

Safety of ON 01910.Na in Patients With Myelodysplasia

Who this might be right for
Myelodysplastic Syndrome (MDS)
National Heart, Lung, and Blood Institute (NHLBI) 14
Not applicableLooking for participantsNCT07683104
What this trial is testing

Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related Disorders

Who this might be right for
Trisomy 8 MosaicismTrisomy 8 Associated Autoinflammatory DiseaseMucosal Ulcerations
National Institute of Allergy and Infectious Diseases (NIAID) 750
Testing effectiveness (Phase 2)Study completedNCT00906334
What this trial is testing

Efficacy and Safety of ON 01910.Na in Myelodysplastic Syndrome (MDS) Patients With Trisomy 8 or Classified as Intermediate-1, -2 or High Risk

Who this might be right for
Myelodysplastic Syndrome
Traws Pharma, Inc. 14
Not applicableStudy completedNCT00987584
What this trial is testing

Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1, 2/High Risk

Who this might be right for
Myelodysplastic Syndromes
Peter L Greenberg 13